Drug Database
Back to search

Netherlands· NL-d7b0f4fa8a0c

Comirnaty LP.8.1 30 microgram/dosis dispersie voor injectie in een voorgevulde spuit

A covid-19, rna-based vaccine product containing bnt162b2 omicron (lp.8.1) mrna, registered in Netherlands by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedComirnaty LP.8.1 30 microgram/dosis …ATCJ07BN01REGISTER NO.NL-d7b0f4fa8a0cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bnt162b2 omicron (lp.8.1) mrnaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BNT162b2 OMICRON (LP.8.1) mRNA
Manufacturer
BioNTech Manufacturing GmbH
Country
Netherlands (NL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/20/1528

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d44f5e2e-6767-441b-a0a0-8e08b56bbf38
GET /v1/drugs/d44f5e2e-6767-441b-a0a0-8e08b56bbf38?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp135403",
  "excipients": [
    "((4-HYDROXYBUTYL)AZAANDIYL)BIS(HEXAAN-6,1-DIYL)BIS(2-HEXYLDECANOAAT)",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "2-[(POLYETHYLEENGLYCOL)-2000]-N,N-DITETRADECYLACETAMIDE",
    "CHOLESTEROL",
    "SACCHAROSE",
    "TROMETAMOL",
    "TROMETAMOLHYDROCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "BNT162b2 OMICRON (LP.8.1) mRNA"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/12/21",
  "procedure_number": "EMEA/H/C/005735",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1528",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console